Investing Profile

Vikram Bajaj

InvestorVC

Managing Director at Foresite Capital

foresitecapital.comNevada

Your Intro Paths to Vikram Bajaj

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Vikram is a member of

Google Network

1029 CONNECTIONS

Google Network

1029 CONNECTIONS

Massachusetts Institute of Technology Network

600 CONNECTIONS

Massachusetts Institute of Technology Network

600 CONNECTIONS

University of Pennsylvania Network

502 CONNECTIONS

Find Vikram Bajaj on

Current Investing Position

Foresite Capital Managing Director

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$668M

Vikram Bajaj is on these Sector & Stage Rankings

Consumer Health (Series B)BioTech (Series B)Consumer Health (Series A)BioTech (Seed)Consumer Health (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay Area Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Vikram Bajaj's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Foresight Diagnostics	Series BJul 2024$33M Series BApr 2023$59M	$110M
Co-investors: Shahram Seyedin-Noor (Civilization Ventures), Jim Tananbaum (Foresite Capital Management)
Spear Bio	Series AJul 2024$45M	$45M
Co-investors: David Singer (Maverick Capital)
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Roelof Botha (Sequoia Capital), Greg Yap (Menlo Ventures), Robert Nelsen (ARCH Venture Partners)
Alumis	Series CMar 2024$260M Series AMay 2021$70M	$330M
Co-investors: Michael Rome (Foresite Capital), Jim Tananbaum (Foresite Capital Management), Richard Gaster (venBio Partners)
Pleno	Series AOct 2022$40M	$40M
Co-investors: Andrew ElBardissi (Deerfield Management)
TenSixteen Bio	Series AJan 2022$40M	$40M
Co-investors: Krishna Yeshwant (GV (Google Ventures))
Interline Therapeutics	Series AMay 2021$60M	$60M
Co-investors: Jay Parrish (ARCH Venture Partners)
Tesseract Health	Series BApr 2021$80M	$80M
Co-investors: Jim Tananbaum (Foresite Capital Management)

Vikram Bajaj's Experience

Disaster Services American Red CrossPresent

Proj. Scientist (Principal Investigator) Lawrence Berkeley National LaboratoryPresent

Research Scientist (Principal Investigator) BerkeleyLawPresent

Scientist (Principal Investigator) Lawrence Berkeley National LaboratoryPresent

Research Scientist (Principal Investigator) University of California, BerkeleyPresent

Member, Economic Development Board The City of El CerritoPresent

Adjunct Professor Stanford Center for Clinical Research (SCCR)Present

(Consulting) Associate Professor of Radiology Stanford University School of MedicinePresent

Advisory Board Member, College of Chemistry University of California, BerkeleyPresent

Advisory Board Member, College of Chemistry BerkeleyLawPresent

Chief Scientific Officer GrailPresent

Chair, Science Board VerilyPresent

Member, Scientific Advisory Board GrailPresent

Managing Director Foresite CapitalPresent

Managing Director Foresite Capital ManagementPresent

Non-Executive Director Genomics EnglandPresent

Director and Interim President Xaira TherapeuticsPresent

Co-Founder Agenea SciencesPresent

Co-Founder SkinScan Inc.Present

Chief Scientific Officer & Co-Founder, Google Life Sciences; Director Google[x] GooglePresent

Chief Scientific Officer & Co-Founder, Google Life Sciences GooglePresent

Co-Founder and Chief Scientific Officer VerilyPresent

CEO and Co-Founder Foresite LabsPresent

Co-founder & Director Xaira TherapeuticsPresent

Co-CEO and Co-Founder PrometheusPresent

Vikram Bajaj's Education

University of Pennsylvania B.A./M.S. Biochemistry

Massachusetts Institute of Technology Ph.D., Physical Chemistry Physical Chemistry

Massachusetts Institute of Technology doctorates, doctor of philosophy chemistry

Investors who invest with Vikram Bajaj

Scouts & Angels Affiliated With Vikram Bajaj